Clostridioides difficile infection hits older adults harder than almost any other age group, causing more severe diarrhea, higher rates of complications, and a significantly greater chance of the infection coming back after treatment. In the United States alone, C. diff accounts for an estimated 240,000 infections and 46,000 deaths per year among elderly patients, with associated healthcare costs exceeding $6 billion annually.1Infection Control & Hospital Epidemiology. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States The reasons older people are so vulnerable, the symptoms to watch for, and what can be done about it are worth understanding whether you are an older adult yourself or caring for one.
Why Older Adults Are So Vulnerable
Three things converge to make C. diff a particular threat as people age. First, the immune system weakens. The body’s ability to mount an effective antibody response against C. diff toxins declines with age, and the innate immune system loses some of its capacity to contain the infection early.2The Journals of Gerontology: Series A. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections Second, the gut microbiome shifts. A healthy, diverse community of gut bacteria normally prevents C. diff from gaining a foothold, but the composition of that community changes with age in ways that weaken this natural defense.3PubMed Central. Clostridium difficile infection in older adults Third, older adults simply spend more time in healthcare settings, where C. diff spores are most abundant, and they take more antibiotics, which destroy the protective bacteria that keep C. diff in check.4PubMed Central. Clostridium difficile infection in the elderly: an update on management
Recognizing the Symptoms
The hallmark symptom of C. diff is watery diarrhea, often occurring three or more times a day. In older adults this can escalate quickly. Abdominal cramping, tenderness, fever, nausea, and loss of appetite are common companions. In more severe cases, the diarrhea becomes bloody, and the person may develop a dangerously swollen colon (toxic megacolon), kidney failure, or sepsis. The trouble with older patients is that some of these warning signs can be mistaken for other conditions common in aging, or the person may not communicate their discomfort clearly, especially if cognitive decline is present.
A particularly worrying feature in older adults is the speed at which dehydration and malnutrition can set in. Even a few days of profuse diarrhea can cause serious fluid and electrolyte imbalances in someone whose reserves are already slim. One review of hospital management found that nutritional support and rehydration were provided in only about 60% and 56% of older patients with C. diff, respectively, suggesting these basic but critical interventions are frequently overlooked.5BMJ Open Quality. Development of a checklist to support management of older patients with Clostridioides difficile infection
How C. Diff Is Diagnosed
Diagnosis usually starts with a stool test. The most sensitive tests detect the genes that code for C. diff toxins using a method called nucleic acid amplification. These tests are fast and accurate at detecting the organism, but they have a significant limitation: they cannot tell the difference between an active infection and someone who is merely carrying C. diff without symptoms.6PubMed. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection This matters because asymptomatic carriage is common in older adults living in nursing homes or who have recently been hospitalized. A positive test without diarrhea does not necessarily mean C. diff is causing harm, and treating it unnecessarily can itself cause problems.
For this reason, many hospitals use a two-step approach: an initial sensitive screening test followed by a second test that looks for the actual toxin protein. The combination helps distinguish colonization from genuine infection. The bottom line for caregivers: if your loved one tests positive but has no diarrhea, ask the doctor whether treatment is truly warranted.
First-Line Treatment
For decades, the antibiotic vancomycin (taken by mouth) was the go-to treatment for C. diff. It still works well for many patients, but a newer antibiotic called fidaxomicin has emerged as a strong alternative, particularly for older adults. In a trial of patients aged 60 and older, an extended-pulsed course of fidaxomicin led to sustained cure in about 70% of patients 30 days after treatment ended, compared with roughly 59% for vancomycin.7The Lancet Infectious Diseases. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged 60 years and older (EXTEND) Across age groups, fidaxomicin was associated with more than a 50% lower risk of recurrence compared to vancomycin, with similar rates of initial cure.8PubMed. Effect of age on treatment outcomes in Clostridium difficile infection
Fidaxomicin’s advantage appears to come from its narrow spectrum of activity: it kills C. diff while leaving more of the surrounding gut bacteria intact, which helps prevent the infection from returning. This is a meaningful benefit in older adults, whose depleted microbiome is already struggling to recover. The side-effect profiles of both drugs are similar, so the choice often comes down to cost and availability, with fidaxomicin being substantially more expensive.
The Recurrence Problem
Recurrence is the defining challenge of C. diff in older adults. After a first episode, some patients clear the infection permanently. But for a significant minority, the infection comes roaring back within weeks of finishing antibiotics. Advanced age, use of additional antibiotics, acid-suppressing medications, and infection with aggressive strains are the major risk factors for recurrence.9PubMed Central. Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
The consequences of recurrence are severe. Deaths associated with C. diff are almost ten times higher after recurrent infection (about 25%) than after a first episode (about 3%).10Journal of the American Medical Directors Association. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults Quality-of-life studies show that older people who survive recurrent C. diff often experience lasting functional decline, increased risk of hospital readmission, and higher mortality even months after the acute episode resolves.11PubMed Central. Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review Each recurrence also drives up healthcare costs dramatically: mean annual costs for patients with even one recurrence exceeded $99,000, compared with about $76,000 for those with no recurrence.12PubMed Central. Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis
Acid-Suppressing Medications and Other Drug Risks
One modifiable risk factor that deserves special attention is acid-suppressing medication, particularly proton pump inhibitors (PPIs) like omeprazole and pantoprazole. These are among the most widely prescribed drugs in older adults, and research consistently shows they raise the risk of both initial and recurrent C. diff. A meta-analysis found that patients on acid-suppressing drugs had a recurrence rate of about 22%, compared with 17% in those not taking them.13JAMA Internal Medicine. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis A systematic review of eight studies confirmed a statistically significant association between PPIs and C. diff infection.14PubMed Central. The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
The picture differs somewhat between community-dwelling older adults and nursing home residents. For people living at home, acid-reducing medications raised the risk of recurrent C. diff by about 2.5 times. For nursing home residents, the increase was nearly threefold.15PubMed. Medication Exposure and Risk of Recurrent Clostridium difficile Infection in Community-Dwelling Older People and Nursing Home Residents Antibiotics, unsurprisingly, also increased recurrence risk in both groups. If you or a family member is recovering from C. diff, it is worth asking the prescribing doctor whether any acid-suppressing medications can safely be stopped or reduced. Many older adults remain on PPIs long after the original reason for prescribing them has passed.
Fecal Microbiota Transplant
When C. diff keeps coming back despite antibiotic treatment, fecal microbiota transplant (FMT) has proven remarkably effective. The idea is straightforward: stool from a healthy donor is introduced into the patient’s gut, restoring the microbial community that C. diff has been exploiting. A review of FMT in 115 older adults (aged 60 to 101) found cure rates of about 90%, with no significant difference in outcomes between older and younger recipients.16PubMed. Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review Most treatment failures occurred in patients infected with the particularly aggressive NAP1/027 strain.
Longer-term follow-up data in elderly patients has been encouraging. One study tracked 29 older patients after FMT for an average of over two years and found no additional adverse events or recurrences beyond the initial treatment period. Adverse events were limited to transient mild fever and bloating in a handful of patients.17PubMed. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes A larger study of 146 elderly patients also confirmed FMT’s safety and effectiveness in this population, including in cases where the infection was severe or complicated.18Journal of Clinical Gastroenterology. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals
Newer Microbiome-Based Therapies and Bezlotoxumab
Traditional FMT requires a screened donor and either a colonoscopy, nasal tube, or enema. Newer products aim to standardize this approach. SER-109 (now marketed as Vowst) is a capsule containing purified bacterial spores derived from donor stool. In its phase 3 trial, C. diff recurrence within eight weeks was 12% in the SER-109 group versus 40% in the placebo group.19New England Journal of Medicine. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection The benefit held up in patients 65 and older, with a recurrence rate still dramatically lower than placebo.20PubMed Central. Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection The introduced bacterial species were detectable in patients’ guts a week after treatment and were linked to bile acid changes that inhibit C. diff spore germination, which is a plausible explanation for why it works.
A completely different approach targets the toxins rather than the bacteria. Bezlotoxumab is a monoclonal antibody given as a single intravenous infusion during antibiotic treatment for C. diff. It binds to toxin B, the main driver of gut damage, and neutralizes it. In two large trials, patients receiving bezlotoxumab had lower rates of recurrence than those receiving placebo, and the benefit was most pronounced in patients with multiple risk factors, including age 65 and older.21PubMed Central. Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies A real-world Italian study confirmed a significant reduction in recurrence at 30 days when bezlotoxumab was added to standard antibiotic therapy, after adjusting for other factors.22International Journal of Infectious Diseases. Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study Bezlotoxumab does not treat the active infection itself; it is specifically aimed at preventing the next episode. For older patients with multiple risk factors for recurrence, it represents an additional tool that can be layered on top of antibiotic treatment.
Prevention Through Hygiene
C. diff spreads through spores that are shed in stool and can survive on surfaces for months. One critical fact that trips people up: standard alcohol-based hand sanitizers do not kill C. diff spores.23PubMed Central. Hand and environmental hygiene: respective roles for MRSA, multi-resistant gram negatives, Clostridioides difficile, and Candida spp. Washing hands with soap and water is the recommended approach for removing the spores through physical friction and rinsing. That said, increased use of alcohol hand gel in healthcare settings has not been linked to higher C. diff rates overall, so the two strategies are complementary rather than at odds.24PubMed Central. Efficacy of cleaning products for C. difficile: environmental strategies to reduce the spread of Clostridium difficile-associated diarrhea in geriatric rehabilitation
Environmental cleaning matters just as much. Bleach-based (sodium hypochlorite) disinfectants are more effective than regular detergents at killing C. diff spores on surfaces. High-touch surfaces in rooms of infected patients should be cleaned daily with a sporicidal agent.23PubMed Central. Hand and environmental hygiene: respective roles for MRSA, multi-resistant gram negatives, Clostridioides difficile, and Candida spp. In long-term care facilities, a comprehensive approach including antimicrobial stewardship, infection surveillance, contact precautions, and sporicidal cleaning is recommended.25PubMed. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review
The Probiotics Question
Probiotics are frequently suggested as a way to prevent C. diff during antibiotic use, but the evidence is more complicated than supplement labels suggest. A large Cochrane review of 31 trials found moderate evidence that probiotics reduced C. diff-associated diarrhea, but only in settings where the baseline risk was above 5%. In lower-risk settings, the benefit was unclear.26PubMed Central. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children However, the Cochrane authors also noted that probiotics appeared safe for people who were not severely debilitated or immunocompromised.
Working against this optimism is one of the largest trials conducted specifically in older hospitalized patients. The PLACIDE trial enrolled nearly 3,000 older adults (aged 65 and over) taking antibiotics and randomized them to receive a multi-strain probiotic preparation or placebo. The result was essentially no difference: antibiotic-associated diarrhea occurred in about 11% of the probiotic group and 10% of the placebo group. C. diff diarrhea was uncommon in both groups (under 1.2%), and the trend toward reduced C. diff in the probiotic arm was not statistically significant.27The Lancet. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE) The bottom line: probiotics are unlikely to harm most older adults, but the evidence that they meaningfully prevent C. diff in this population is weak.
Antibiotic Stewardship in Nursing Homes
Because antibiotics are the single biggest modifiable trigger for C. diff, reducing unnecessary antibiotic prescribing is one of the most effective prevention strategies. This is especially relevant in nursing homes, where antibiotics are frequently prescribed for conditions like urinary tract infections that may not always require them. A systematic review of antibiotic stewardship programs in nursing homes found that most reduced antibiotic prescriptions and improved guideline adherence, though none individually demonstrated a statistically significant drop in C. diff rates.28PubMed. Antibiotic Stewardship Programs in Nursing Homes: A Systematic Review
More targeted interventions have shown clearer results. A program specifically focused on reducing fluoroquinolone use (a class of antibiotics strongly linked to C. diff) through a hospital-nursing home partnership achieved an 18% reduction in C. diff rates.29Journal of the American Medical Directors Association. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital–Nursing Home Collaboration Another program that targeted unnecessary antibiotic use for suspected urinary tract infections cut C. diff infections by 65% in the intervention facilities compared with controls.30JAMA Internal Medicine. A Multifaceted Antimicrobial Stewardship Program for the Treatment of Uncomplicated Cystitis in Nursing Home Residents These numbers suggest that the most effective way to prevent C. diff in care facilities is not a single silver-bullet intervention but a sustained effort to question whether each antibiotic prescription is truly necessary.
What Caregivers Can Do at Home
For families caring for an older adult during or after a C. diff episode, a few practical points can make a genuine difference. Keep a close eye on fluid intake. Older adults often do not feel thirsty even when dehydrated, and C. diff diarrhea drains fluids fast. Encourage small, frequent sips of water and electrolyte-containing liquids throughout the day. Watch for signs of dehydration like dark urine, dizziness, confusion, or dry mouth.
Clean bathroom surfaces daily with a bleach-based cleaner. C. diff spores are invisible, resistant to standard household cleaners, and can survive on toilet seats, sink handles, and bed rails for extended periods. Anyone helping the patient with toileting or cleaning up after episodes should wash hands thoroughly with soap and water afterward, not just use hand sanitizer.
Ask the medical team to review all current medications. As noted earlier, acid-suppressing drugs and unnecessary antibiotics are the most actionable risk factors for recurrence. If your family member is prescribed a new antibiotic for a separate issue while recovering from C. diff, it is worth confirming with the doctor that the antibiotic is truly needed and that the narrowest effective option has been chosen. A careful medication review after a C. diff episode can reduce the odds of the cycle repeating itself.